Form 4 for LYEL Lyell Immunopharma, Inc.
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-14 · accession 0001209191-21-069485 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-12-14 | 2021-12-14 | LYEL | FRIEDMAN CATHY | Dir | J - Other | $0.00 | -3.55M | 236.4K | -94% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-14 | J | D | 3,765,842 | $0.00 | 0 | I Lyell Investors, LLC | — | — | (F1) Pro-rata distribution by Lyell Investors, LLC to its members. |
| 2 | Common | Common Stock | 2021-12-14 | J | A | 218,722 | $0.00 | 236,370 | I MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST | — | — | (F2) Received in a pro-rata distribution from Lyell Investors, LLC. The Reporting Person is a trustee of MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST ("Duane Family Trust") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Family Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Family Trust except to any pecuniary interest therein. |